piperazine has been researched along with Asthma in 5 studies
Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).
| Excerpt | Relevance | Reference |
|---|---|---|
| "The presence of specific IgE antibodies against conjugates between human serum albumin and piperazine, a compound previously known to cause occupational asthma, and N-methyl-piperazine, respectively, was demonstrated by RAST, RAST inhibition and skin prick tests in 2 asthmatic subjects occupationally exposed to these agents." | 7.67 | IgE antibodies against piperazine and N-methyl-piperazine in two asthmatic subjects. ( Gustavsson, C; Hagmar, L; Welinder, H, 1986) |
| "The heterocyclic secondary amine piperazine is known to cause asthma." | 3.67 | Piperazine-induced airway symptoms: exposure-response relationships and selection in an occupational setting. ( Bellander, T; Hagmar, L; Ranstam, J; Skerfving, S, 1984) |
| "An N2 wash-out technique was used to estimate the small airways function in 22 male workers, exposed to the asthma-inducing amine piperazine, and in 22 referent subjects, with similar smoking habits and age." | 3.67 | Small airways function in workers exposed to piperazine. ( Arborelius, M; Bellander, T; Hagmar, L; Skerfving, S; Welinder, H, 1987) |
| "The presence of specific IgE antibodies against conjugates between human serum albumin and piperazine, a compound previously known to cause occupational asthma, and N-methyl-piperazine, respectively, was demonstrated by RAST, RAST inhibition and skin prick tests in 2 asthmatic subjects occupationally exposed to these agents." | 3.67 | IgE antibodies against piperazine and N-methyl-piperazine in two asthmatic subjects. ( Gustavsson, C; Hagmar, L; Welinder, H, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, Y | 2 |
| Wu, Y | 1 |
| Qi, H | 1 |
| Xiao, J | 1 |
| Gong, H | 1 |
| Xu, E | 1 |
| Li, S | 1 |
| Ma, D | 1 |
| Wang, Y | 1 |
| Li, W | 1 |
| Shen, H | 1 |
| Moshe, S | 1 |
| Yagev, Y | 1 |
| Hagmar, L | 3 |
| Bellander, T | 2 |
| Ranstam, J | 1 |
| Skerfving, S | 2 |
| Arborelius, M | 1 |
| Welinder, H | 2 |
| Gustavsson, C | 1 |
5 other studies available for piperazine and Asthma
| Article | Year |
|---|---|
A new antagonist for CCR4 attenuates allergic lung inflammation in a mouse model of asthma.
Topics: Animals; Asthma; Cell Migration Inhibition; Cell Survival; Disease Models, Animal; HEK293 Cells; Hum | 2017 |
[Summary of the ICOH 2009 Conference - Cape Town, South Africa].
Topics: Acquired Immunodeficiency Syndrome; Asthma; Congresses as Topic; Humans; Piperazine; Piperazines; So | 2009 |
Piperazine-induced airway symptoms: exposure-response relationships and selection in an occupational setting.
Topics: Asthma; Bronchitis; Dose-Response Relationship, Drug; Environmental Exposure; Humans; Male; Occupati | 1984 |
Small airways function in workers exposed to piperazine.
Topics: Adult; Asthma; Bronchial Provocation Tests; Humans; Male; Middle Aged; Nitrogen; Occupational Diseas | 1987 |
IgE antibodies against piperazine and N-methyl-piperazine in two asthmatic subjects.
Topics: Adult; Air Pollutants, Occupational; Asthma; Humans; Immunoglobulin E; Male; Occupational Diseases; | 1986 |